Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-12 01:12 | 2025-08-07 | BBIO | BridgeBio Pharma, Inc. | Kumar Neil | Director, Officer | SELL | $45.84 | 80,000 | $3,666,952 | 915,686 |
| 2025-08-12 01:51 | 2025-08-07 | ELVN | Enliven Therapeutics, Inc. | Patel Anish | Officer | SELL | $18.24 | 6,667 | $121,615 | 289,975 |
| 2025-08-12 00:07 | 2025-06-17 | BYSI | BeyondSpring Inc. | Decheng Capital China Life Sciences USD Fund III, L.P. | 10% owner | SELL | $3.05 | 394,436 | $1,204,055 | 891,734 |
| 2025-08-11 23:35 | 2025-08-11 | RPRX | Royalty Pharma plc | Norden Gregory | Director | SELL | $36.23 | 33,500 | $1,213,749 | 194,848 |
| 2025-08-11 23:09 | 2025-08-07 | PCRX | Pacira BioSciences, Inc. | BIGAL MARCELO | Director | SELL | $23.67 | 4,912 | $116,267 | 11,393 |
| 2025-08-11 16:12 | 2025-07-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Young Caroline | Director | BUY | $3.44 | 168 | $578 | 32,821 |
| 2025-08-11 16:00 | 2025-07-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Jones James | Director | BUY | $3.43 | 340 | $1,166 | 43,676 |
| 2025-08-11 15:39 | 2025-07-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | Krogulski Kenneth | Director | BUY | $3.43 | 1,712 | $5,872 | 288,345 |
| 2025-08-11 15:50 | 2025-07-01 | CPIX | CUMBERLAND PHARMACEUTICALS INC | KAZIMI A J | Director, Officer, 10% owner | BUY | $3.43 | 340 | $1,166 | 5,699,768 |
| 2025-08-08 22:13 | 2025-08-07 | GOVX | GeoVax Labs, Inc. | McKee Kelly T. Jr. | Officer | BUY | $0.67 | 1,107 | $742 | 3,494 |
| 2025-08-08 23:30 | 2025-08-07 | NUVL | Nuvalent, Inc. | Pelish Henry E. | Officer | OPT+S | $74.85 | 5,500 | $411,675 | 60,956 |
| 2025-08-08 23:50 | 2025-08-07 | MIRM | Mirum Pharmaceuticals, Inc. | Howe Jolanda | Officer | OPT+S | $58.00 | 10,000 | $580,000 | 2,426 |
| 2025-08-08 23:35 | 2025-08-06 | KNSA | Kiniksa Pharmaceuticals International, plc | Paolini John F. | Officer | OPT+S | $32.55 | 29,325 | $954,529 | 57,403 |
| 2025-08-08 23:49 | 2025-08-07 | MIRM | Mirum Pharmaceuticals, Inc. | Peetz Christopher | Director, Officer | OPT+S | $55.25 | 40,000 | $2,210,040 | 138,641 |
| 2025-08-08 23:20 | 2025-08-08 | LLY | ELI LILLY & Co | JACKSON JAMERE | Director | BUY | $639.56 | 200 | $127,913 | 9,402 |
| 2025-08-09 00:45 | 2025-08-06 | RNA | Avidity Biosciences, Inc. | Mosbrooker Eric | Officer | OPT+S | $44.06 | 130,807 | $5,763,697 | 55,000 |
| 2025-08-09 00:39 | 2025-08-06 | RNA | Avidity Biosciences, Inc. | Hughes Steven George | Officer | OPT+S | $42.74 | 81,434 | $3,480,269 | 38,867 |
| 2025-08-09 00:42 | 2025-08-06 | RNA | Avidity Biosciences, Inc. | WILSON TROY EDWARD | Director | OPT+S | $45.00 | 95,054 | $4,277,430 | 17,776 |
| 2025-08-08 18:45 | 2025-08-08 | PRGO | PERRIGO Co plc | Lockwood-Taylor Patrick | Director, Officer | BUY | $22.37 | 4,460 | $99,766 | 85,812 |
| 2025-08-08 23:56 | 2025-08-08 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner | BUY | $1.32 | 675,000 | $891,000 | 214,676,448 |
| 2025-08-08 23:40 | 2025-08-06 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | Director, Officer | OPT+S | $42.02 | 140,000 | $5,883,360 | 1,069,933 |
| 2025-08-08 23:05 | 2025-08-07 | VNDA | Vanda Pharmaceuticals Inc. | Polymeropoulos Mihael Hristos | Director, Officer | BUY | $4.15 | 10,000 | $41,500 | 2,335,731 |
| 2025-08-09 00:41 | 2025-08-06 | RNA | Avidity Biosciences, Inc. | LEVIN ARTHUR A | Director | OPT+S | $47.62 | 107,500 | $5,118,881 | 19,650 |
| 2025-08-08 23:31 | 2025-08-07 | UTHR | UNITED THERAPEUTICS Corp | MAHON PAUL A | Officer | OPT+S | $300.00 | 11,000 | $3,299,980 | 36,781 |
| 2025-08-09 01:55 | 2025-08-06 | IONS | IONIS PHARMACEUTICALS INC | PARSHALL B LYNNE | Director | SELL | $41.93 | 5,000 | $209,646 | 86,344 |
| 2025-08-07 16:00 | 2025-08-05 | AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Officer | OPT+S | $49.30 | 12,500 | $616,299 | 167,124 |
| 2025-08-07 23:50 | 2025-08-05 | BBIO | BridgeBio Pharma, Inc. | Ellis Andrea | Director | OPT+S | $49.00 | 17,167 | $841,183 | 18,589 |
| 2025-08-07 23:23 | 2025-08-06 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | Director, Officer | BUY | $389.58 | 10,000 | $3,895,768 | 115,968 |
| 2025-08-07 23:40 | 2025-08-05 | KNSA | Kiniksa Pharmaceuticals International, plc | Tessari Eben | Officer | OPT+S | $33.20 | 138,614 | $4,602,373 | 49,915 |
| 2025-08-07 23:30 | 2025-08-05 | LQDA | Liquidia Corp | Kaseta Michael | Officer | SELL | $20.00 | 30,000 | $600,132 | 376,412 |
| 2025-08-08 03:00 | 2025-08-05 | WVE | Wave Life Sciences Ltd. | TAKANASHI KEN | Director | SELL | $8.75 | 4,872 | $42,630 | 5,716,303 |
| 2025-08-08 03:00 | 2025-08-05 | WVE | Wave Life Sciences Ltd. | Tan Aik Na | Director | SELL | $8.75 | 1,127 | $9,861 | 14,988 |
| 2025-08-08 00:00 | 2025-08-05 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Director | SELL | $60.95 | 395 | $24,075 | 625,082 |
| 2025-08-08 00:00 | 2025-08-05 | ABBV | AbbVie Inc. | Donoghoe Nicholas | Officer | SELL | $198.51 | 13,295 | $2,639,253 | 58,247 |
| 2025-08-07 23:19 | 2025-08-06 | VRTX | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | BUY | $389.68 | 5,000 | $1,948,416 | 45,000 |
| 2025-08-08 02:17 | 2025-08-05 | CORT | CORCEPT THERAPEUTICS INC | Guyer William | Officer | OPT+S | $71.77 | 14 | $1,005 | 5,487 |
| 2025-08-07 23:15 | 2025-08-05 | AIMD | Ainos Inc. | Taiwan Carbon Nano Technology Corp | 10% owner | SELL | $2.77 | 31,191 | $86,249 | 1,048,912 |
| 2025-08-06 23:30 | 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Ragosa Mark | Officer | OPT+S | $32.89 | 18,889 | $621,259 | 27,009 |
| 2025-08-07 03:38 | 2025-08-06 | VSTM | Verastem, Inc. | Paterson Dan | Director, Officer | SELL | $5.81 | 1,332 | $7,739 | 442,507 |
| 2025-08-06 23:30 | 2025-08-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Megna Michael R | Officer | OPT+S | $32.35 | 17,000 | $549,950 | 33,041 |
| 2025-08-07 01:44 | 2025-08-05 | IONS | IONIS PHARMACEUTICALS INC | Geary Richard S | Officer | SELL | $42.86 | 10,000 | $428,593 | 89,492 |
| 2025-08-07 00:22 | 2025-08-04 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer | OPT+S | $5.17 | 5,500 | $28,435 | 0 |
| 2025-08-06 23:19 | 2025-08-04 | INSM | INSMED Inc | Flammer Martina M.D. | Officer | OPT+S | $109.50 | 8,715 | $954,293 | 83,111 |
| 2025-08-06 23:21 | 2025-08-04 | INSM | INSMED Inc | Lewis William | Director, Officer | OPT+S | $109.81 | 6,830 | $750,008 | 233,924 |
| 2025-08-05 23:04 | 2025-08-01 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Jover Placid | Officer | OPT+S | $15.16 | 6,053 | $91,748 | 6,774 |
| 2025-08-05 23:02 | 2025-08-01 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Hughes Eric A | Officer | OPT+S | $15.16 | 52,742 | $799,437 | 0 |
| 2025-08-06 00:28 | 2025-08-04 | IONS | IONIS PHARMACEUTICALS INC | Schneider Eugene | Officer | SELL | $42.80 | 9,549 | $408,701 | 51,507 |
| 2025-08-06 01:29 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd | Director, Officer | SELL | $14.33 | 11,547 | $165,429 | 901,569 |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Vairavan Latha | Officer | SELL | $14.33 | 89 | $1,275 | 65,015 |
| 2025-08-06 01:28 | 2025-08-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer | SELL | $14.33 | 6,330 | $90,687 | 197,364 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.